Home > Compound List > Product Information
Vinflunine Ditartrate_Molecular_structure_CAS_194468-36-5)
Click picture or here to close

Vinflunine Ditartrate

Catalog No. V314500 Name Toronto Research Chemicals
CAS Number 194468-36-5 Website http://www.trc-canada.com
M. F. C49H60F2N4O14 Telephone +1 (416) 665-9696
M. W. 967.0159064 Fax +1 (416) 665-4439
Purity Email info@trc-canada.com
Storage -20°C Freezer Chembase ID: 179511

SYNONYMS

IUPAC name
(2R,3R)-2,3-dihydroxybutanedioic acid methyl (1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-4-[(12S,14S)-16-(1,1-difluoroethyl)-12-(methoxycarbonyl)-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraen-12-yl]-12-ethyl-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate
IUPAC Traditional name
L(+)-tartaric acid methyl (1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-4-[(1R,12S,14S)-16-(1,1-difluoroethyl)-12-(methoxycarbonyl)-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraen-12-yl]-12-ethyl-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate
Synonyms
4'-Deoxy-20',20'-difluoro-5'-nor-vincaleukoblastine Ditartrate
(2β,3β,4β,5α,12β,19α)-4-(Acetyloxy)-6,7-didehydro-15-[(2R,4R,6S,8S)-4-(1,1-difluoroethyl)-1,3,4,5,6,7,8,9-octahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methylaspidospermidine-3-carboxylic Acid Methyl Ester (2R,3R)-2,3-Dihydroxybutanedioate
BMS 710485
Javlor
20',20'-Difluoro-3',4'-dihydrovinorelbine Ditartrate
F 12158

DATABASE IDS

CAS Number 194468-36-5

PROPERTIES

Certificate of Analysis Download
Apperance White Solid
Melting Point 244-246°C (dec)
Solubility DMSO
MSDS Link Download
Storage Condition -20°C Freezer

DETAILS

Description (English)
Vinflunine is a semisynthetic Vinca alkaloid with microtubule destabilizing and antiangiogenic activity. Vinflunine is a derivative of Vinorelbine. Vinflunine is used as an antineoplastic.

REFERENCES

  • Kruczynski, A., et al.: Crit. Rev. Oncol. Hematol., 40, 159 (2001)
  • Fabre, C., et al.: Biochem. Pharmacol., 64, 733 (2001)
  • Bennouna, J. et al.: Ann. Oncol., 14, 630 (2001)
  • Bennouna, J., et al.: Expert Opin. Invest. Drugs, 14, 1259 (2005).